Elucidata
PrivateLast Round
Series A
Sep 27, 2022
Total Funding Raised
$17.7M
Company Overview
Elucidata is a healthtech company that provides an AI and cloud-based data analytics platform, Polly, for life sciences research and drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Healthcare Analytics, ML Platforms, Data Integration, Precision Medicine
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS, Data as a Service
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elucidata Comparables
Compare Elucidata with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TetraScience | 85% | |
| Data4Cure, Inc. | 83% | |
| DNAnexus | 79% | |
Elucidata Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 27, 2022 | ||||
| VC Round | Feb 4, 2021 | ||||
| Seed | Jun 19, 2018 |
Key People
Founding team and executive leadership
Elucidata Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eight Roads Ventures | Series A |
| IvyCap Ventures | Series A, VC Round |
| F-Prime Capital | Series A |
| Hyperplane Venture Capital | Series A, VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 31, 2026
Monthly visitors increased 62% MoM.
- May 1, 2025
Monthly visitors increased 52% MoM.
Elucidata Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Elucidata's valuation, stock price, and market status.